|
|
 |
|
Viewing report
|
|
|
|
European Immunochemistry Analysers Markets
Frost & Sullivan, Jan 2008, Pages: 71
This Frost & Sullivan research service titled European Immunochemistry Analysers Markets provides an overview of immunochemistry analysers with their revenues. It provides a complete analysis of key market drivers, restraints and trends in the market. Finally, it provides strategic solutions that vendors can adopt to gain advantage in this growing market. Within the scope of this research service, immunochemistry analysers are defined as revenues generated through instrumentation only, which are performed primarily in hospital laboratories.
Market Overview
Expanded Range of Tests Promote the Growing Appeal of Immunochemistry Analysers
The immunochemistry analyser market in Europe is less mature than most other clinical laboratory analyser markets and has experienced higher growth due to the demand for new technology and systems with expanded test menus. Thyroid, cardiac and cancer testing are among the key test types that are spurring the demand for immunochemistry systems. Additionally, immunochemistry costs more than its clinical chemistry counterparts, thereby contributing to higher overall revenues. Immunochemistry analysers function on the principal antigen-antibody reactions and are utilised to diagnose a variety of diseases and health conditions. Immunochemistry systems analyse blood, saliva and urine and utilise several methodologies including enzyme immunoassay (EIA), coated micro plates, chemiluminescence and fluorescence. Immunochemistry tests include tests for thyroid function, cardiac and cancer markers, fertility/reproductive markers, infectious disease and retroviral markers, metabolic markers and therapeutic drug monitoring.
Immunochemistry analysers are integrated analysers that combine clinical chemistry and immunoassay technologies. These analysers are typically offered in modular increments, which can operate independently or simultaneously as a unit, fulfilling around 80 per cent of testing requirements within high- and medium-sized diagnostic laboratories. Escalating test costs and increasing budgetary constraints are the major reasons behind the widespread adoption and success of these analysers. 'Although vendors are still involved in refining and improving the analyser capabilities of these immunochemistry analysers, the wide reach of this concept will improve their sales,' notes the analyst of this research. 'Furthermore, with more new entrants into this market, the immunochemistry analyser market will experience good competition and this, in turn, is set to benefit the clinical laboratories.'
Limited Hospital Budgets and High Switching Costs Inhibit Market Expansion
The penetration level of immunochemistry analysers in Europe is high. However, limited budgets are reducing the capability of hospitals to invest in immunochemistry analysers. Another challenge relates to the hesitation of clinical laboratories to switch to a different brand of analysers due to the costs associated with the transition, which can involve retraining staff, restandardising practices and updating data management systems. Occasionally, even when laboratory managers and personnel are dissatisfied with their current instrument or service, they baulk at purchasing another manufacturer's product because the decision process and implementation can take a long time. Purchasing decisions often lie with levels of management other than that of laboratory managers. This results in difficulties related to purchasing appropriate instruments, as these decision makers are unaware of the intricate details of immunochemistry instruments as well as the needs of laboratories. Consequently, laboratories may not be able to obtain or even negotiate the terms for the most suitable equipment for their operations.
'In light of increasing revenues from immunochemistry analyser sales, manufacturers should promote pre and post sample management and integration options to boost revenue streams from instrumentation sales,' advises the analyst. 'Additionally, customers should be encouraged to upgrade to integrated immunochemistry systems to increase productivity and reduce labour costs in the long term.' Enhanced levels of automation will also result in customers being tied down to a single vendor, while allowing vendors to successfully generate more long-term revenues from a single customer site.
Expert Frost & Sullivan analysts thoroughly examine the following sectors in this research:
By Product Type:
- Laboratory-based testing - Immunochemistry Instruments
By Geographic Region:
- Germany
- France
- The United Kingdom
- Italy
- Spain
- Scandinavia (Denmark, Finland, Norway and Sweden)
- Benelux (Belgium, the Netherlands and Luxembourg)
|
|
|
|
